Association between quantitative CT body composition analysis and prognosis in cetuximab-based first-line treatment for advanced colorectal cancer patients
This study was approved by the Ethics Committee of Anhui Provincial Cancer Hospital of Anhui Medical University (Batch No:2024-ZNY-02). All subjects signed an informed consent form.
Authors
- Yaolin Chen
- Fei Gao (ORCID: https://orcid.org/0000-0003-3633-3133)
- Wenxi Dang (ORCID: https://orcid.org/0000-0003-3553-7556)
- Hao Shen (ORCID: https://orcid.org/0000-0003-3368-9185)
- Xudong Liu (ORCID: https://orcid.org/0000-0003-2911-4899)
- Zhihua Zhang (ORCID: https://orcid.org/0000-0002-8508-2409)
- Haoyu Wang (ORCID: https://orcid.org/0000-0002-6367-303X)
- Zhen Cai (ORCID: https://orcid.org/0000-0001-6026-3804)
- Shusheng Wu (ORCID: https://orcid.org/0000-0003-1084-8630)
- Mengge Li (ORCID: https://orcid.org/0000-0003-1337-1823)
- Yifu He (ORCID: https://orcid.org/0000-0003-1990-0298)
- Mingjie Sun (ORCID: https://orcid.org/0009-0000-1800-0381)
Institutions
- University of Science and Technology of China (CN)
- Anhui Medical University (CN)
- Anhui Provincial Hospital (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1186/s12885-024-13338-8
- Citations
- 4
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.13
Funders
- Anhui Medical University
- Anhui Provincial Cancer Hospital